ÃÑ 951ÆäÀÌÁö

502ÆäÀÌÁö º»¹®½ÃÀÛ

2014
³ó¸²Ãà»ê°Ë¿ª°Ë»ç±â¼ú°³¹ß»ç¾÷ ¿¬±¸°úÁ¦Á¦¾È¼­
2. Clavijo A., Wright P., Kitching P. 2004, Developments in diagnostic techniques for
differentiating infection from vaccination in foot-and-mouth disease.
The Veterinary Journal. 167: 9-22.
3. Doel T.R., Chong W.K.T. 1982. Comparative immunogenecity of 146S, 75S and 12S
particles of foot-and-mouth disease virus. Archives of Virology 73:185-191.
4. Hamblin C, Barnett IT, Hedger RS. 1986, A new enzyme-linked immunosorbent assay
(ELISA) for the detection of antibodies against foot-and-mouth disease virus. I.
Development and method of ELISA. J Immunol Methods. 93(1):115-21.
5. Hamblin C, Kitching RP, Donaldson AI, Crowther JR, Barnett IT, 1987, Enzyme-linked
immunosorbent assay (ELISA) for the detection of antibodies against foot-and-mouth
disease virus. III. Evaluation of antibodies after infection and vaccination.
Epidemiol Infect. 99(3):733-44.
6. Ko YJ, Lee HS, Park JH, Lee KN, Kim SM, Cho IS, Joo HD, Paik SG, Paton DJ,
Parida S. 2012, Field application of a recombinant protein-based ELISA during the
2010 outbreak of foot-and-mouth disease type A in South Korea. J Virol Methods.
179(1):265-8.
7. Van Maanen C, Terpstra C. 1989, Comparison of a liquid-phase blocking sandwich
ELISA and a serum neutralization test to evaluate immunity in potency tests of
foot-and-mouth disease vaccines. J Immunol Methods. 124(1):111-9.
6
³ó¸²Ãà»ê°Ë¿ªº»ºÎ

502ÆäÀÌÁö º»¹®³¡



ÇöÀç Æ÷Ä¿½ºÀÇ ¾Æ·¡³»¿ëµéÀº µ¿ÀÏÇÑ ÄÁÅÙÃ÷¸¦ °¡Áö°í ÆäÀÌÁö³Ñ±è È¿°ú¹× ½Ã°¢Àû È¿°ú¸¦ Á¦°øÇÏ´Â ÆäÀÌÁöÀ̹ǷΠ½ºÅ©¸°¸®´õ »ç¿ëÀÚ´Â ¿©±â±îÁö¸¸ ³¶µ¶ÇϽðí À§ÀÇ ÆäÀÌÁöÀ̵¿ ¸µÅ©¸¦ »ç¿ëÇÏ¿© ´ÙÀ½ÆäÀÌÁö·Î À̵¿ÇϽñ⠹ٶø´Ï´Ù.
»ó´Ü¸Þ´º ¹Ù·Î°¡±â ´ÜÃàÅ°¾È³» : ÀÌÀüÆäÀÌÁö´Â ÁÂÃø¹æÇâÅ°, ´ÙÀ½ÆäÀÌÁö´Â ¿ìÃø¹æÇâÅ°, ùÆäÀÌÁö´Â »ó´Ü¹æÇâÅ°, ¸¶Áö¸·ÆäÀÌÁö´Â ÇϴܹæÇâÅ°, ÁÂÃøÈ®´ëÃà¼Ò´Â insertÅ°, ¿ìÃøÈ®´ëÃà¼Ò´Â deleteÅ°